Abstract
Colloids and crystalloids are frequently use to restore intravascular volume. Both solutions interfere with the coagulation process in different ways. Increasing amounts of fluids result in dilutional coagulopathy. Artificial colloids exert additive effects on fibrin polymerisation and platelet function. In vitro and in vivo studies revealed that starches and dextrans show the greatest negative impact on hemostasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander B, Odake K et al (1975) Coagulation, hemostasis, and plasma expanders:a quarter century enigma. Fed Proc 34(6):1429–1440
Angle N, Hoyt DB et al (1998) Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 9(3):164–170
Batlle J, del Rio F et al (1985) Effect of dextran on factor VIII/von Willebrand factor structure and function. Thromb Haemost 54(3):697–699
Brodin B, Hesselvik F et al (1984) Decrease of plasma fibronectin concentration following infusion of a gelatin-based plasma substitute in man. Scand J Clin Lab Invest 44(6):529–533
Brummel-Ziedins K, Whelihan MF et al (2006) The resuscitative fluid you choose may potentiate bleeding. J Trauma 61(6):1350–1358
Bulger EM, May S et al (2010) Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 304(13):1455–1464
Bulger EM, May S et al (2011) Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 253(3):431–441
Bunn F, Trivedi D (2012) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 7:CD001319
Casutt M, Kristoffy A et al (2010) Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth 105(3):273–281
Choi PT, Yip G et al (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27(1):200–210
Clagett GP, Anderson FA Jr et al (1995) Prevention of venous thromboembolism. Chest 108(4 Suppl):312S–334S
Coats TJ, Heron M (2004) The effect of hypertonic saline dextran on whole blood coagulation. Resuscitation 60(1):101–104
Coats TJ, Brazil E et al (2006) The effects of commonly used resuscitation fluids on whole blood coagulation. Emerg Med J 23(7):546–549
Conroy JM, Fishman RL et al (1996) The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 83(4):804–807
de Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29(6):1261–1267
de Jonge E, Levi M et al (1998) Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 79(2):286–290
Denis R, Smith RW et al (1987) Relocation of nonalbumin proteins after albumin resuscitation. J Surg Res 43(5):413–419
Deusch E, Gamsjager T et al (2003) Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 97(3):680–683
Deusch E, Thaler U et al (2004) The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 99(3):665–668
Dunbar NM, Chandler WL (2009) Thrombin generation in trauma patients. Transfusion 49(12):2652–2660
Egli GA, Zollinger A et al (1997) Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 78(6):684–689
Engvall E, Ruoslahti E et al (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 147(6):1584–1595
Entholzner EK, Mielke LL et al (2000) Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 44(9):1116–1121
Eriksson M, Saldeen T (1995) Effect of dextran on plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) during surgery. Acta Anaesthesiol Scand 39(2):163–166
Evans PA, Glenn JR et al (1998) Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 81(2):198–202
Evans PA, Heptinstall S et al (2003) Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. J Thromb Haemost 1(10):2140–2148
Fenger-Eriksen C, Tonnesen E et al (2009) Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 7(7):1099–1105
Finfer S, Bellomo R et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22):2247–2256
Franz A, Braunlich P et al (2001) The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 92(6):1402–1407
Fries D, Martini WZ (2010) Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 105(2):116–121
Fries D, Innerhofer P et al (2002) The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG. Anesth Analg 94(5):1280–1287
Fries D, Krismer A et al (2005) Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 95(2):172–177
Gamsjager T, Gustorff B et al (2002) The effects of hydroxyethyl starches on intracellular calcium in platelets. Anesth Analg 95(4):866–869
Grottke O, Braunschweig T et al (2010) Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 14(2):R62
Guidet B, Soni N et al (2010) A balanced view of balanced solutions. Crit Care 14(5):325
Haas T, Fries D et al (2008a) Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesth Analg 106(4):1078–1086
Haas T, Fries D et al (2008b) The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 106(5):1360–1365
Hanke AA, Maschler S et al (2011) In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch. Scand J Trauma Resusc Emerg Med 19:12
Hauser CJ, Shoemaker WC et al (1980) Oxygen transport responses to colloids and crystalloids in critically ill surgical patients. Surg Gynecol Obstet 150(6):811–816
Innerhofer P, Fries D et al (2002) In vivo effect of haemodilution with saline on coagulation. Br J Anaesth 89(6):934
Jacob M, Chappell D et al (2012) The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans. Crit Care 16(3):R86
James MF, Michell WL et al (2011) Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107(5):693–702
Jamnicki M, Zollinger A et al (1998) Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 87(5):989–993
Jamnicki M, Bombeli T et al (2000) Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 93(5):1231–1237
Jesty J (1986) The kinetics of inhibition of alpha-thrombin in human plasma. J Biol Chem 261(22):10313–10318
Jin SL, Yu BW (2010) Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost 16(1):91–98
Johnson AL, Criddle LM (2004) Pass the salt: indications for and implications of using hypertonic saline. Crit Care Nurse 24(5):36–38
Johnson SD, Lucas CE et al (1979) Altered coagulation after albumin supplements for treatment of oligemic shock. Arch Surg 114(4):379–383
Jones SB, Whitten CW et al (2003) The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 96(2):363–368
Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44(7):681–699
Jungheinrich C, Sauermann W et al (2004) Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study. Drugs R D 5(1):1–9
Kapiotis S, Quehenberger P et al (1994) Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 22(4):606–612
Karoutsos S, Nathan N et al (1999) Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 82(2):175–177
Kasper SM, Meinert P et al (2003) Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99(1):42–47
Kermode JC, Zheng Q et al (1999) Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94(1):199–207
Kheirabadi BS, Crissey JM et al (2008) Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. J Trauma 64(5):1218–1228
Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103(3):654–660
Kozek-Langenecker SA (2009) Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 23(2):225–236
Kulla M, Lampl L et al (2008) Hydroxyethyl starch 6% 130/0.42 in acetate-buffered Ringer's solution as a part of a balanced-volume resuscitation in abdominal surgery. Anästhesiol Intensivmed 1:7–18
Langeron O, Doelberg M et al (2001) Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92(4):855–862
Laxenaire MC, Mertes PM (2001) Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 87(4):549–558
Lucas CE, Ledgerwood AM et al (1982) Altered coagulation protein content after albumin resuscitation. Ann Surg 196(2):198–202
Mardel SN, Saunders FM et al (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80(2):204–207
McIlroy DR, Kharasch ED (2003) Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg 96(6):1572–1577
Meng ZH, Wolberg AS et al (2003) The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 55(5):886–891
Mittermayr M, Streif W et al (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105(4):905–917
Mittermayr M, Streif W et al (2008) Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 100(3):307–314
Mortier E, Ongenae M et al (1997) In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 52(11):1061–1064
Myburgh J, Cooper DJ et al (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357(9):874–884
Neff TA, Doelberg M et al (2003) Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96(5):1453–1459
Ng KF, Lam CC et al (2002) In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 88(4):475–480
Niemi TT, Silvanto M et al (2005) Albumin induced hypercoagulability does not reduce blood loss in patients undergoing total hip arthroplasty. Scand J Surg 94(3):227–232
Niemi TT, Suojaranta-Ylinen RT et al (2006) Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 102(4):998–1006
Perel P, Roberts I (2012) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 6:CD000567
Perner A, Haase N et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367(2):124–134
Petroianu GA, Liu J et al (2000) The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 90(4):795–800
Rehm M, Finsterer U (2003) Treating intraoperative hyperchloremic acidosis with sodium bicarbonate or tris-hydroxymethyl aminomethane: a randomized prospective study. Anesth Analg 96(4):1201–1208, table of contents
Roberts I, Blackhall K et al (2011) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (11):CD001208
Ruttmann TG (2002) Haemodilution enhances coagulation. Br J Anaesth 88(4):470–472
Ruttmann TG, James MF et al (1996) Haemodilution induces a hypercoagulable state. Br J Anaesth 76(3):412–414
Ruttmann TG, Jamest MF et al (2001) Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 29(5):489–493
Ruttmann TG, Lemmens HJ et al (2006) The haemodilution enhanced onset of coagulation as measured by the thrombelastogram is transient. Eur J Anaesthesiol 23(7):574–579
Scatchard G, Batchelder AC et al (1944) Chemical, Clinical, and Immunological Studies on the Products of Human Plasma Fractionation. Vi. The Osmotic Pressure of Plasma and of Serum Albumin. J Clin Invest 23(4):458–464
Schaden E, Wetzel L et al (2012) Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation. Br J Anaesth 109(4):572–577
Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316(7136):961–964
Schlimp CJ, Cadmoro J et al (2013) The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33 % diluted blood with albumin, gelatin, hydroxyethyl starch or saline in vitro. Blood Transfus 11(4):510–517
Schramko AA, Kuitunen AH et al (2009) Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution. Acta Anaesthesiol Scand 53(6):731–735
Schramko A, Suojaranta-Ylinen R et al (2010) Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 104(6):691–697
Smith GJ, Kramer GC et al (1985) A comparison of several hypertonic solutions for resuscitation of bled sheep. J Surg Res 39(6):517–528
Sorensen B, Fries D (2012) Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 99(Suppl 1):40–50
Sossdorf M, Marx S et al (2009) HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Crit Care 13(6):R208
Stogermuller B, Stark J et al (2000) The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 91(4):823–827
Strauss RG, Pennell BJ et al (2002) A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 42(1):27–36
Tabuchi N, de Haan J et al (1995) Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 74(6):1447–1451
Thaler U, Deusch E et al (2005) In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions. Anaesthesia 60(6):554–559
Tollofsrud S, Tonnessen T et al (1998) Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid volumes. Acta Anaesthesiol Scand 42(2):145–153
Treib J, Haass A et al (1996) Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases. Arzneimittelforschung 46(11):1064–1066
Treib J, Baron JF et al (1999) An international view of hydroxyethyl starches. Intensive Care Med 25(3):258–268
Van der Linden P, Ickx BE (2006) The effects of colloid solutions on hemostasis. Can J Anaesth 53(6 Suppl):S30–S39
Van der Linden P, Schmartz D (1992) Pharmacology of gelatins. In: Plasma volume expansion. J. F. Baron/Arenette, Paris, pp 67–74
Van der Linden PJ, De Hert SG et al (2005) Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 101(3):629–634
Velasco IT, Pontieri V et al (1980) Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 239(5):H664–H673
Waters JH, Gottlieb A et al (2001) Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 93(4):817–822
Westphal M, James MF et al (2009) Hydroxyethyl starches: different products–different effects. Anesthesiology 111(1):187–202
Wilder DM, Reid TJ et al (2002) Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thromb Res 107(5):255–261
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schöchl, H., Schlimp, C., Voelckel, W. (2015). Intravenous Fluids and Coagulation. In: Marcucci, C., Schoettker, P. (eds) Perioperative Hemostasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55004-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-55004-1_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55003-4
Online ISBN: 978-3-642-55004-1
eBook Packages: MedicineMedicine (R0)